Sugi Predict

Sugi Predict / Compounds / SCHEMBL10088640

SCHEMBL10088640

SCHEMBL10088640

O=CC1=Cc2c(F)cc(OCc3ccc(-c4ccccc4)cc3C(F)(F)F)cc2OC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGER4 P35408 4/20 0.36
▸ HDAC1 Q13547 1/20 0.34
▸ HDAC6 Q9UBN7 1/20 0.34
▸ HDAC5 Q9UQL6 1/20 0.34
▸ S1PR1 P21453 1/20 0.34
▸ NR1H2 P55055 5/20 0.33
▸ NR1H3 Q13133 4/20 0.33
▸ GBA1 P04062 2/20 0.33
▸ UGCG Q16739 2/20 0.33
▸ GBA2 Q9HCG7 2/20 0.33
▸ MGAM O43451 1/20 0.33
▸ LCT P09848 1/20 0.33
▸ SI P14410 1/20 0.33
▸ AR P10275 1/20 0.32
▸ RXRA P19793 2/20 0.32
▸ KIF11 P52732 1/20 0.32
▸ NAAA Q02083 1/20 0.32
▸ MAOB P27338 1/20 0.32
▸ ADAMTS4 O75173 1/20 0.31
▸ MMP13 P45452 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10088581 0.88 AR (0.34) HDAC1HDAC6HDAC5NR1H2NR1H3
SCHEMBL10088904 0.87 SRD5A1 (0.37) S1PR1ARMAOBALOX5
SCHEMBL10088465 0.86 SRD5A1 (0.31) AR
SCHEMBL10088577 0.86 SLC6A4 (0.34) ARALOX5ALOX5AP
SCHEMBL10310541 0.85 EPHX2 (0.36) AR
SCHEMBL10088583 0.84 FFAR4 (0.30) —
SCHEMBL10088578 0.83 MAOB (0.38) HDAC1HDAC6HDAC5S1PR1GBA1
SCHEMBL10088534 0.81 MAOA (0.31) S1PR1MAOB
SCHEMBL10088579 0.81 RXRA (0.33) RXRA
SCHEMBL10088947 0.80 S1PR1 (0.45) S1PR1MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120178735-A1 2H-CHROMENE COMPOUND AND DERIVATIVE THEREOF ASTELLAS PHARMA INC. (JP) 2012-07-12 — — US disclosed
US-20120178735-A1 2H-CHROMENE COMPOUND AND DERIVATIVE THEREOF ASTELLAS PHARMA INC. (JP) 2012-07-12 — — US disclosed
US-8193378-B2 2H-chromene compound and derivative thereof ASTELLAS PHARMA INC. (JP) 2012-06-05 — — US disclosed
US-8193378-B2 2H-chromene compound and derivative thereof ASTELLAS PHARMA INC. (JP) 2012-06-05 — — US disclosed
US-20110230463-A1 2H-CHROMENE COMPOUND AND DERIVATIVE THEREOF ASTELLAS PHARMA INC. (JP) 2011-09-22 — — US disclosed
US-20110230463-A1 2H-CHROMENE COMPOUND AND DERIVATIVE THEREOF ASTELLAS PHARMA INC. (JP) 2011-09-22 — — US disclosed
WO-2010064707-A1 2H-CHROMENE COMPOUND AND DERIVATIVE THEREOF アステラス製薬株式会社 (JP) 2010-06-10 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110230463-A1 2H-CHROMENE COMPOUND AND DERIVATIVE THEREOF S1PR1, S1PR2, CCR1 PTGER4 979/4885HDAC1 2222/4885HDAC6 4352/4885
US-20120178735-A1 2H-CHROMENE COMPOUND AND DERIVATIVE THEREOF S1PR1, S1PR2, S1PR4 PTGER4 710/4885HDAC1 1589/4885HDAC6 4140/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.